BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2781890)

  • 21. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
    Plu-Bureau G; Horellou MH; Gompel A; Conard J
    Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of risk factors associated with vascular thrombosis in women on oral contraceptives. Possible role of anti-sex steroid hormone antibodies.
    Beaumont V; Lemort N; Beaumont JL
    Artery; 1983; 11(5):331-44. PubMed ID: 6661039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hormonal contraceptive agents as a risk factor in the development of acute thromboembolic diseases].
    Lambrekht R; Vageman V; Vinkelman B; Geĭnrikh P
    Khirurgiia (Mosk); 1986 Dec; (12):90-3. PubMed ID: 3821001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormone therapy and cardiovascular risk].
    Wütschert R; Cirafici P
    Praxis (Bern 1994); 2000 Jun; 89(25-26):1090-7. PubMed ID: 11367591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Estrogen-progestin contraception and cardiovascular diseases: the end of polemics on the third generation].
    Jamin C
    Contracept Fertil Sex; 1998 May; 26(5):331-7. PubMed ID: 9648376
    [No Abstract]   [Full Text] [Related]  

  • 26. [Risk of thromboembolism in contraception and hormone substitution: an update and recommendations].
    van den Brûle F; Gaspard U
    J Pharm Belg; 2004; 59(1):38-40. PubMed ID: 15129579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Contraceptive agents and risk of thrombosis].
    Maurer-Major E; Keller PJ
    Praxis (Bern 1994); 1997 Oct; 86(40):1543-8. PubMed ID: 9417570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hormonal contraceptives. Uses--risks].
    Breckwoldt M
    Geburtshilfe Frauenheilkd; 1989 Jun; 49(6):521-2. PubMed ID: 2663616
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pregnancy, contraception and HRT and venous thromboembolism].
    Conard J; Gompel A
    Rev Prat; 2007 Apr; 57(7):759-66. PubMed ID: 17626321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP; Deitcher SR
    Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of family history in identifying women with thrombophilia and higher risk of venous thromboembolism during oral contraception.
    Cosmi B; Legnani C; Bernardi F; Coccheri S; Palareti G
    Arch Intern Med; 2003 May; 163(9):1105-9. PubMed ID: 12742811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oral contraceptives and elective surgery. Strategies in Norwegian hospitals, thromboembolic complications and perioperative conception].
    Dale O; Skjeldestad FE
    Tidsskr Nor Laegeforen; 1995 Mar; 115(8):938-40. PubMed ID: 7709382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Low-dose acetylsalicylic acid].
    Creutzig A
    Dtsch Med Wochenschr; 1997 Oct; 122(42):1299. PubMed ID: 9378069
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter: Preoperative discontinuation of contraceptives.
    Drill VA
    N Engl J Med; 1974 May; 290(22):1265. PubMed ID: 4825863
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cardiovascular diseases with oral contraceptives: risks and benefits].
    Heinemann L
    Z Arztl Fortbild (Jena); 1990; 84(1-2):43-6. PubMed ID: 2184599
    [No Abstract]   [Full Text] [Related]  

  • 36. [How to classify hormonal contraceptives?].
    Jamin C
    J Gynecol Obstet Biol Reprod (Paris); 2012 Apr; 41(2):103-4. PubMed ID: 22377640
    [No Abstract]   [Full Text] [Related]  

  • 37. [Oral contraceptives and cerebral thromboembolism. A Danish case-control study].
    Lidegaard O
    Ugeskr Laeger; 1993 Nov; 155(44):3538-45. PubMed ID: 8236574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lowering the steroid dose in oral contraception and risk of functional ovarian cysts].
    Mayenga JM; Segard L; Cohen J; Belaïsch-Allart J
    Contracept Fertil Sex; 1995; 23(7-8):439-41. PubMed ID: 7550556
    [No Abstract]   [Full Text] [Related]  

  • 39. [Contraceptives and systemic lupus erythematosus].
    Wagner J; Andrassy K
    Hautarzt; 1991 Nov; 42(11):726. PubMed ID: 1769838
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current oral hormonal contraception ].
    Markov D
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():6-8. PubMed ID: 19504701
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.